Sparrow Healthcare LLC

Sparrow Healthcare LLC was paid $1.01M by Medicaid between Apr 2020 and Sep 2021, across 14 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 59% of everything it billed.

33Billing provider infoSPARROW HEALTHCARE LLC
THE WOODLANDS, TX 77380

33aNPI1134748460assigned 04/16/2020

33bProvider typeClinical Medical Laboratory

28Total paid$1.01M

24GClaims34,365

24DCodes billed14

24AFirst – last monthApr 2020 – Sep 2021

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#68 of 436

Median peer was paid$17K

This provider vs. median59×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	17,125	$532K
2021	17,240	$478K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	59%	14,253	5,735	$591K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	26%	7,145	3,139	$267K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	9.9%	8,205	3,133	$100K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.9%	686	497	$19K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	234	214	$10K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,071	700	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	477	419	$6K
87581		<1%	453	415	$2K
87631		<1%	234	215	$2K
87541		<1%	455	417	$2K
87486		<1%	455	417	$2K
87640		<1%	455	417	$2K

2 more codes

87496		<1%	121	$270.11
87498		<1%	121	$210.53

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWEXLER, JAKE (OWNER)

Same official

Other billing entities under WEXLER, JAKE

Full network →

Provider	Location	Paid
Halo Labs LLC	Spring, TX	$52K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.